+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capricor Therapeutics - logo

Capricor Therapeutics focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials. It is also developing Exosomes for the treatment of cardiovascular and non-cardiovascular diseases. The company was founded in 2005 and is headquartered in Beverly Hills, California.

Licensing Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1250 Pages
  • Global
From
Exosome Technologies Market Report 2025 - Product Thumbnail Image

Exosome Technologies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
RNA Delivery Technologies, 2021: Frost Radar Report - Product Thumbnail Image

RNA Delivery Technologies, 2021: Frost Radar Report

  • Report
  • November 2021
  • 40 Pages
  • Global
From
From
From
From
Loading Indicator